PineBridge Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

PineBridge Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,566	Closed	-$397K	–	1143
2017 Q3	$397K	Sell	22,566 -7,796	-26%	-$175K	0.01%	731
2017 Q2	$1.01M	Sell	30,362 -2,537	-8%	-$78.5K	0.03%	497
2017 Q1	$1.06M	Buy	+32,899	New	+$1.12M	0.03%	480
2016 Q2	–	Sell	-138,124	Closed	-$7.39M	–	1170
2016 Q1	$7.39M	Buy	+138,124	New	+$8.1M	0.38%	88

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

PineBridge Investments's TEVA Position: Q4 2017 in Review

PineBridge Investments sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2017, closing a stake of 22,566 shares — an estimated $397K sold.

PineBridge Investments first reported a position in TEVA in Q1 2016 and held it in 4 quarters. The position peaked at $7.39M in Q1 2016. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

PineBridge Investments reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2017 after selling out during the quarter.
PineBridge Investments sold 22,566 Teva Pharmaceutical Industries Limited shares in Q4 2017, an estimated $397K.
PineBridge Investments first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and held it in 4 quarters.
PineBridge Investments's Teva Pharmaceutical Industries Limited position peaked at $7.39M in Q1 2016.
508 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2017.

Based on PineBridge Investments's 13F filing for Q4 2017, filed 9 Feb 2018.